Use of fpt inhibitors and at least two antineoplastic agents...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/496 (2006.01) A61K 31/454 (2006.01) A61K 31/473 (2006.01) A61K 31/4745 (2006.01) A61K 31/525 (2006.01) A61K 31/704 (2006.01) A61K 31/7076 (2006.01) A61K 39/395 (2006.01) A61K 45/06 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2468996

Disclosed is a use of an FPT inhibitor for the manufacture of a medicament for the treatment of cancer (e.g., non small cell lung cancer, squamous cell cancer of the head and neck, CML, AML, non-Hodgkin's lymphoma and multiple myeloma), said treatment comprising the administration of said medicament and therapeutically effective amounts of one or more antineoplastic agents.

L'invention concerne l'utilisation d'un inhibiteur de FPT afin de fabriquer un médicament servant à traiter le cancer (par exemple, le cancer bronchopulmonaire "non à petites cellules", l'épithéliome malpighien spinocellulaire de la tête et du cou, CML, AML, le lymphome non Hodgkinien ou le myélome multiple), ledit traitement consistant à administrer ledit médicament et des quantités efficaces sur le plan thérapeutique de deux ou de plusieurs agents antinéoplasiques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of fpt inhibitors and at least two antineoplastic agents... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of fpt inhibitors and at least two antineoplastic agents..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of fpt inhibitors and at least two antineoplastic agents... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1384797

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.